Novartis Investigative Site is a clinical research site located in Saginaw, Michigan, United States 48604.
Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.
Novartis Investigative Site has participated in 12 clinical trials with 1 currently active.
Therapeutic areas: Heart Failure and Reduced Ejection Fraction, Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease (CAD).
Sponsors: Novartis Pharmaceuticals, Mereo BioPharma.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Michigan · View every site in Saginaw
Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Novartis Investigative Site has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Novartis Investigative Site has 12 clinical trials on record, with 1 currently active. Their work covers Heart Failure and Reduced Ejection Fraction, Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease (CAD).
Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.